Dexketoprofen

Chemical formula: C₁₆H₁₄O₃  Molecular mass: 254.281 g/mol  PubChem compound: 667550

Therapeutic indications

Dexketoprofen is indicated for:

Mild to moderate pain

Population group: only adults (18 years old or older)

Symptomatic treatment of pain of mild to moderate intensity, such as musculo-skeletal pain, dysmenorrhoea, dental pain.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Dexketoprofen is contraindicated in the following cases:

Severe hepatic dysfunction

Hepatic failure stage IV

Moderate renal impairment, severe renal impairment

at least one of



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Peptic ulcer, gastrointestinal haemorrhage

at least one of
Peptic ulcer
Gastrointestinal hemorrhage
H/O: peptic ulcer
History of gastrointestinal bleed
Gastrointestinal perforation
NSAID-associated gastropathy

Chronic dyspepsia

Indigestion

Patients with haemorrhagic diathesis, coagulation disorders

at least one of
Bleeding
At risk of hemorrhage
Blood coagulation disorder

Crohn's disease, ulcerative colitis

at least one of
Crohn's disease
Colitis gravis

Severe heart failure

Heart failure

Active bleedings or bleeding disorders

at least one of
Bleeding
Blood coagulation disorder

Severe dehydration

Severe dehydration

Pregnancy

Pregnancy

Lactation

Lactation

Photoallergic or phototoxic reactions

at least one of
Phototoxic dermatitis
Photoallergic dermatitis

Hypersensitivity to any other NSAID

at least one of
Non-allergic hypersensitivity to non-steroidal anti-inflammatory agent
Non-steroidal anti-inflammatory drug allergy

Patients in whom substances with a similar action precipitate attacks of asthma or or cause nasal polyps

at least one of
Aspirin-induced asthma
Bronchospasm caused by drug
NSAID-induced angio-oedema-urticaria

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: KERAL Film-coated tablet
Summary of Product Characteristics (SPC) 2023: KERAL Solution for injection/infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈